These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 16362889)
1. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889 [TBL] [Abstract][Full Text] [Related]
2. Cardiac output and organ blood flow in experimental septic shock: effect of treatment with antibiotics, corticosteroids, and fluid infusion. Ottosson J; Dawidson I; Brandberg A; Idvall J; Sandor Z Circ Shock; 1991 Sep; 35(1):14-24. PubMed ID: 1742857 [TBL] [Abstract][Full Text] [Related]
8. [The effect of some drugs on the levels of selected cytokines in experimental septic shock]. Ladny JR; Dzienis H; Dadan J; Polaków J; Venskutonis D; Puchalski Z Wiad Lek; 1997; 50 Suppl 1 Pt 2():247-51. PubMed ID: 9424882 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice. Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW Clin Microbiol Infect; 2006 Nov; 12(11):1105-11. PubMed ID: 17002610 [TBL] [Abstract][Full Text] [Related]
10. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. Hiromatsu T; Yajima T; Matsuguchi T; Nishimura H; Wajjwalku W; Arai T; Nimura Y; Yoshikai Y J Infect Dis; 2003 May; 187(9):1442-51. PubMed ID: 12717626 [TBL] [Abstract][Full Text] [Related]
12. [Protective effect of ketamine against septic shock in rats]. Song XM; Li JG; Wang YL; Zhou Q; Du ZH; Jia BH; Hu ZF; Li P Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):348-51. PubMed ID: 15182446 [TBL] [Abstract][Full Text] [Related]
13. Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lactate-does it really make a difference? Su F; Wang Z; Cai Y; Rogiers P; Vincent JL Shock; 2007 May; 27(5):520-6. PubMed ID: 17438457 [TBL] [Abstract][Full Text] [Related]
14. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis. Lally KP; Cruz E; Xue H J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025 [TBL] [Abstract][Full Text] [Related]
15. [The effects of somatostatin on serum interleukin-6 and tumor necrosis factor-alpha in lipopolysaccharide-induced septic shock: experiment with rats]. Zhu TJ; Dong GR; Huang GQ; Fan XP; Liu B; Zhang ZL Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):345-7. PubMed ID: 17456366 [TBL] [Abstract][Full Text] [Related]
16. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Manley MO; O'Riordan MA; Levine AD; Latifi SQ Shock; 2005 Jun; 23(6):521-6. PubMed ID: 15897804 [TBL] [Abstract][Full Text] [Related]
18. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model. Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632 [TBL] [Abstract][Full Text] [Related]
19. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis. Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686 [TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice. Tkalcević VI; Bosnjak B; Pasalić I; Hrvacić B; Situm K; Kramarić MD; Glojnarić I; Eraković Haber V Int J Antimicrob Agents; 2008 Aug; 32(2):195-6. PubMed ID: 18571382 [No Abstract] [Full Text] [Related] [Next] [New Search]